(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 11.60%-325.83K | 34.65%-962.39K | 128.53%132.11K | -6.66%-310.98K | -44.36%-413.92K | 14.53%-368.59K | 14.15%-1.47M | -168.36%-463.05K | 54.72%-291.55K | 34.93%-286.73K |
Net income from continuing operations | 65.27%-159.1K | -106.57%-4.45M | -240.14%-3M | -21.21%-457.84K | -9.45%-530.87K | -12.09%-458.11K | 0.95%-2.15M | -108.20%-882.31K | 42.07%-377.73K | 15.80%-485.03K |
Operating gains losses | 63.75%3.4K | 184.20%22.23K | 100.09%6 | 154.75%10.23K | 198.16%9.91K | -76.53%2.08K | -288.74%-26.4K | -248.18%-6.47K | -591.87%-18.69K | -375.78%-10.1K |
Depreciation and amortization | 43.84%7.83K | 8.05%23.51K | 1.25%5.51K | 30.96%7.12K | -0.02%5.44K | 0.02%5.44K | 27.12%21.76K | 152.60%5.44K | -66.79%5.44K | -46.58%5.44K |
Asset impairment expenditure | ---- | 637.05%2.53M | ---- | ---- | ---- | ---- | --342.68K | ---- | ---- | ---- |
Remuneration paid in stock | -133.86%-39.69K | 45.02%537.91K | -9.99%115.15K | 32.26%150.82K | 20.25%154.73K | 40,884.62%117.22K | -9.49%370.92K | 715.49%127.93K | -28.96%114.03K | -10.70%128.68K |
Other non cashItems | --105K | ---- | ---- | ---- | ---- | ---- | 662.15%32.14K | -483.33%-7.91K | 839.88%20.25K | --17.83K |
Change In working capital | -590.86%-243.27K | 729.38%377.17K | 1,247.68%486.82K | 38.87%-21.31K | -194.11%-53.13K | 9.97%-35.21K | -531.79%-59.93K | -117.71%-42.42K | 80.04%-34.85K | 350.26%56.45K |
-Change in receivables | ---- | -57.43%17.33K | 609.58%90.02K | -1,396.56%-36.2K | -142.43%-30.02K | ---- | 240.46%40.72K | -106.87%-17.67K | 101.33%2.79K | 253.98%70.75K |
-Change in prepaid assets | ---- | 168.62%46.38K | 155.96%40.3K | 215.04%19.38K | -132.10%-17.03K | ---- | -37.35%-67.59K | -1,499.55%-72.02K | 60.35%-16.84K | 2,731.80%53.07K |
-Change in payables and accrued expense | ---- | 1,048.24%313.46K | 654.19%356.5K | 78.45%-4.48K | 90.98%-6.08K | ---- | -135.90%-33.06K | 308.52%47.27K | -252.72%-20.8K | -178.44%-67.37K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 11.60%-325.83K | 34.65%-962.39K | 128.53%132.11K | -6.66%-310.98K | -44.36%-413.92K | 14.53%-368.59K | 14.15%-1.47M | -168.36%-463.05K | 54.72%-291.55K | 34.93%-286.73K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 21.33%-176.43K | 41.41%-2.91M | 71.07%-547.14K | -25.86%-1.69M | 23.85%-451.68K | 80.36%-224.27K | 46.54%-4.97M | 42.97%-1.89M | 72.25%-1.34M | 22.98%-593.17K |
Capital expenditure reported | 20.74%-176.43K | 16.36%-1.67M | 22.75%-376.26K | -193.99%-624.8K | 24.38%-447.26K | 68.51%-222.6K | 75.89%-2M | 84.16%-487.08K | 94.93%-212.53K | 8.46%-591.43K |
Net PPE purchase and sale | --0 | 65.34%-51.74K | 100.43%145 | -783.68%-45.79K | -154.49%-4.42K | 98.61%-1.67K | 85.11%-149.27K | 85.97%-33.73K | 101.05%6.7K | 98.60%-1.74K |
Net business purchase and sale | ---- | 52.59%-1.19M | 87.52%-171.03K | 10.41%-1.02M | ---- | ---- | ---2.51M | ---1.37M | ---1.13M | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---314.7K | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 21.33%-176.43K | 41.41%-2.91M | 71.07%-547.14K | -25.86%-1.69M | 23.85%-451.68K | 80.36%-224.27K | 46.54%-4.97M | 42.97%-1.89M | 72.25%-1.34M | 22.98%-593.17K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -65.49%668.6K | -42.14%1.94M | 0 | 0 | 0 | 2,295.10%1.94M | -77.03%3.35M | 36,442.28%3.03M | 501.91%30.71K | -98.60%203.99K |
Net issuance payments of debt | --668.6K | --0 | --0 | --0 | --0 | --0 | -3.07%-12.13K | --0 | 92.25%-425 | ---5.33K |
Net common stock issuance | --0 | -36.02%1.94M | ---- | ---- | --0 | --1.94M | -79.21%3.03M | ---- | ---- | --0 |
Cash dividends paid | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | --0 | ---- | 1,065.41%336.53K | --0 | --31.5K | 647.25%215.78K |
Interest paid (cash flow from financing activities) | ---- | --0 | --0 | --0 | --0 | ---- | 10.15%-3.79K | --0 | 83.05%-365 | ---1.45K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -65.49%668.6K | -42.14%1.94M | --0 | --0 | --0 | 2,295.10%1.94M | -77.03%3.35M | 36,442.28%3.03M | 501.91%30.71K | -98.60%203.99K |
Net cash flow | ||||||||||
Beginning cash position | -94.89%105.43K | -59.98%2.06M | -62.18%512.99K | -14.83%2.53M | -6.85%3.4M | -59.98%2.06M | 223.38%5.15M | -84.32%1.36M | -78.95%2.98M | 381.15%3.65M |
Current changes in cash | -87.63%166.34K | 37.38%-1.94M | -161.10%-415.03K | -24.78%-2M | -28.07%-865.6K | 190.11%1.34M | -186.53%-3.09M | 119.43%679.31K | 70.79%-1.6M | -105.05%-675.9K |
Effect of exchange rate changes | -400.78%-23.86K | -1,373.43%-20.71K | -70.51%7.47K | -32.13%-23.13K | -3,635.14%-1.31K | 23.64%-4.76K | 111.63%1.63K | 680.66%25.33K | -360.81%-17.51K | 101.01%37 |
End cash Position | -92.71%247.91K | -94.89%105.43K | -94.89%105.43K | -62.18%512.99K | -14.83%2.53M | -6.85%3.4M | -59.98%2.06M | -59.98%2.06M | -84.32%1.36M | -78.95%2.98M |
Free cash from | 15.28%-502.26K | 26.08%-2.69M | 75.07%-244.01K | -89.95%-981.57K | 1.62%-865.6K | 52.89%-592.86K | 67.00%-3.63M | 71.96%-978.85K | 90.56%-516.74K | 27.33%-879.89K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.